http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1210940-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_593017b07c1a2928ef75f316925f4cb3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
filingDate 2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2097d840fd365d144d7b59442243ca7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bab49373650d1d3806cb1f0ed3bd7277
publicationDate 2003-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1210940-A3
titleOfInvention Antifatigue composition comprising an imidazole compound
abstract An antifatigue composition by which muscular fatigue or the like during or after exercise can be reduced, is obtained by incorporating an imidazole compound, which may be obtained from extracts of fish, shellfish, fowl, flesh or the like, as an active ingredient. The imidazole compound is preferably at least one selected from the group consisting of histidine, anserine, carnosine and valenine, and salts thereof. It is further preferred to contain D-ribose as an active ingredient in the composition. By orally ingesting the antifatigue composition of the present invention, the amount of lactic acid in plasma during or after exercise can be kept low, and therefore the fatigue of muscles by exercise can be controlled. As a result, effects for improving the ability of exercise can be expected.
priorityDate 2000-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9806278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6094075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0652012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9006102-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0324227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0710485-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0873754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0983726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0894439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0449787-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9965476-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5397786-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59210871-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID112072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420329
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420328

Total number of triples: 45.